MAGGIO, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 598
EU - Europa 379
AS - Asia 230
AF - Africa 44
OC - Oceania 1
SA - Sud America 1
Totale 1.253
Nazione #
US - Stati Uniti d'America 595
SG - Singapore 85
IT - Italia 84
CN - Cina 75
SE - Svezia 73
GB - Regno Unito 68
DE - Germania 58
VN - Vietnam 30
IE - Irlanda 25
CI - Costa d'Avorio 24
IN - India 24
CH - Svizzera 17
TG - Togo 13
FR - Francia 10
RU - Federazione Russa 10
ID - Indonesia 8
FI - Finlandia 7
BE - Belgio 5
BG - Bulgaria 5
JO - Giordania 5
NG - Nigeria 4
UA - Ucraina 4
EE - Estonia 3
HU - Ungheria 3
ZA - Sudafrica 3
MX - Messico 2
NL - Olanda 2
AU - Australia 1
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
IR - Iran 1
KR - Corea 1
MD - Moldavia 1
NO - Norvegia 1
PL - Polonia 1
RO - Romania 1
TR - Turchia 1
Totale 1.253
Città #
Chandler 93
Singapore 81
Southend 59
Fairfield 57
Ashburn 39
Princeton 31
Santa Clara 31
Seattle 26
Dublin 25
Wilmington 25
Abidjan 24
Boardman 22
Houston 22
Woodbridge 21
Ann Arbor 16
Bern 16
Cambridge 14
Turin 14
Lomé 13
Berlin 12
Bologna 12
Florence 11
Beijing 9
Helsinki 7
Milan 7
Westminster 7
Guangzhou 6
Jakarta 6
Amman 5
Des Moines 5
Sofia 5
Abeokuta 4
Bentivoglio 4
Bremen 4
Brussels 4
London 4
Redmond 4
San Diego 4
Brescia 3
Budapest 3
Jinan 3
Nanjing 3
Saint Petersburg 3
San Francisco 3
San Jose 3
Zhengzhou 3
Bühl 2
Changsha 2
Frankfurt am Main 2
Hangzhou 2
New York 2
Noicattaro 2
North Kuta 2
Padova 2
Phoenix 2
Shenyang 2
Xochimilco 2
Baoding 1
Boydton 1
Canberra 1
Cesena 1
Changzhou 1
Chengdu 1
Chisinau 1
Copenhagen 1
Council Bluffs 1
Dallas 1
Den Haag 1
Dongguan 1
Forlimpopoli 1
Forlì 1
Fremont 1
Guiyang 1
Haikou 1
Hamm 1
Harbin 1
Istanbul 1
Jiaxing 1
Jinhua 1
Jinzhong 1
Kuban 1
Lanzhou 1
Leawood 1
Linfen 1
Magdeburg 1
Magenta 1
Manchester 1
Medford 1
Mehr 1
Monmouth Junction 1
Montreal 1
Nanchang 1
Nanning 1
Nanyang 1
Oklahoma City 1
Olalla 1
Orta di Atella 1
Oslo 1
Paris 1
Pavia 1
Totale 838
Nome #
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 172
ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors—A systematic review and meta-analysis of real world data 124
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 118
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 108
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations 93
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis. 87
Therapeutic options in lung neuroendocrine tumors: between established concepts and new hopes 72
Landscape and future perspectives of immunotherapy in neuroendocrine neoplasia 70
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases 66
The functioning side of the pancreas: a review on insulinomas 64
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review 60
Third-and later-line treatment in advanced or metastatic gastric cancer: A systematic review and meta-analysis 59
Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: A systematic review 45
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light 43
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 41
Meningioma: Not always a benign tumor. A review of advances in the treatment of meningiomas 41
Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report 32
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma 25
Totale 1.320
Categoria #
all - tutte 4.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.758


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020125 0 0 0 0 0 22 19 25 18 23 18 0
2020/2021136 22 1 4 1 16 6 5 4 17 15 3 42
2021/2022255 4 5 9 7 24 5 6 30 20 31 74 40
2022/2023418 33 44 13 52 30 38 17 31 93 12 29 26
2023/202495 13 17 6 8 4 15 2 10 2 8 2 8
2024/2025232 28 53 37 25 68 21 0 0 0 0 0 0
Totale 1.320